5-(2-Carboxyethenyl) isatin derivative induces G2/M cell cycle arrest and apoptosis in human leukemia K562 cells

Biochemical and Biophysical Research Communications

Volumn 450, Issue 4, 2014, Pages 1650-1655

  Zhou, Yao ^a   Zhao, Hong Ye ^a   Han, Kai Lin ^a   Yang, Yao ^a   Song, Bin Bin ^a   Guo, Qian Nan ^a   Fan, Zhen Chuan ^a,b   Zhang, Yong Min ^c   Teng, Yu Ou ^a   Yu, Peng ^a  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Obesita and Algaegen LLC   (United States)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Apoptosis; Cell cycle; Isatin derivatives

Indexed keywords

APOPTOSIS; CELL CYCLE; ISATIN DERIVATIVES;

ACRYLATES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; G2 PHASE; HUMANS; ISATIN; K562 CELLS; MITOCHONDRIA;

EID: 84906086116     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.053     Document Type: Article

References (26)

1. M. Verma, S.N. Pandeya, and K.N. Singh et al. Anticonvulsant activity of schiff bases of isatin derivatives Acta Pharm. 54 2004 49 56
2. P. Pakravan, S. Kashanian, and M.M. Khodaei et al. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity Pharmacol. Rep. 65 2013 313 335
3. K.L. Vine, L. Matesic, and J.M. Locke et al. Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008 Anticancer Agents Med. Chem. 9 2009 397 414
4. K.C. Chaluvaraju, and Zaranappa Synthesis and biological evaluation of some isatin derivatives for antimicrobial properties Res. J. Pharm. Biol. Chem. Sci. 2 2011 541 546
5. K.S. Seshaiah, and R. Atmakuru Synthesis and pharmacological activities of hydrazones, schiff and mannich bases of isatin derivatives Biol. Pharm. Bull. 24 2001 1149 1152
6. A. Cane, M.C. Tournaire, and D. Barritault et al. The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic Biochem. Biophys. Res. Commun. 276 2000 379 384
7. K.L. Vine, J.M. Locke, and M. Ranson et al. In vitro cytotoxicity evaluation of some substituted isatin derivatives Bioorg. Med. Chem. 15 2007 931 938
8. T. Aboul-Fadl, A.A. Radwan, and M.I. Attia et al. Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity Chem. Cent. J. 30 2012 49 59
9. R. Sabet, M. Mohammadpour, and A. Sadeghi et al. QSAR study of isatin analogues as in vitro anti-cancer agents Eur. J. Med. Chem. 45 2010 1113 1118
10. R.J. Motzer, M.D. Michaelson, and B.G. Redman et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma J. Clin. Oncol. 24 2006 16 24
11. H. Prenen, J. Cools, and N. Mentens et al. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate Clin. Cancer Res. 12 2006 2622 2627
12. W. Chu, J. Rothfuss, and A. d'Avignon et al. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase-3/7 inhibitors J. Med. Chem. 50 2007 3751 3755
13. W. Chu, J. Zhang, and C. Zeng et al. N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies J. Med. Chem. 48 2005 7637 7647
14. Q. Wang, R.H. Mach, and D.E. Reichert Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors J. Chem. Inf. Model. 49 2009 1963 1973
15. I. Sekine, J.D. Minna, and K. Nishio et al. Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: a literature review Jpn. J. Clin. Oncol. 37 2007 329 336
16. S. Lim, and P. Kaldis Cdks, cyclins and CKIs: roles beyond cell cycle regulation Development 140 2013 3079 3093
17. Z.A. Stewart, M.D. Westfall, and J.A. Pietenpol Cell-cycle dysregulation and anticancer therapy Trends Pharmacol. Sci. 24 2003 139 145
18. Y.S. Wu, and S.N. Chen Apoptotic cell: linkage of inflammation and wound healing Front. Pharmacol. 5 2014 1 6
19. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
20. K. Sinha, J. Das, and P.B. Pal et al. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis Arch. Toxicol. 87 2013 1157 1180
21. J.D. Robertson, and S. Orrenius Role of mitochondria in toxic cell death Toxicology 181-182 2002 491 496
22. M. Poreba, A. Strozyk, and G.S. Salvesen et al. Caspase substrates and inhibitors Cold Spring Harb. Perspect. Biol. 5 2013 a008680
23. K. Han, Y. Zhou, and F. Liu et al. Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl) isatin derivatives as anticancer agents Bioorg. Med. Chem. Lett. 24 2014 591 594
24. J.D. Ly, D.R. Grubb, and A. Lawen The mitochondrial membrane potential (Δψm) in apoptosis; an update Apoptosis 8 2003 115 128
25. A. Autret, and S.J. Martin Bcl-2 family proteins and mitochondrial fission/fusion dynamics Cell Mol. Life Sci. 67 2010 1599 1606
26. J.C. Martinou, and R.J. Youle Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics Dev. Cell 21 2011 92 101